Cigna Group (NYSE:CI) Stock Lifted to Buy by Wall Street Zen

Key Points

• Wall Street Zen upgraded Cigna to Buy from Hold. Overall analyst sentiment is a Moderate Buy, with a consensus price target of $335.70.
• Cigna beat quarterly estimates, reporting adjusted EPS of $7.98 versus $7.52 expected and revenue of $73.79 billion versus $72.64 billion expected; revenue rose 5.6% year over year.
• Management raised its 2026 adjusted EPS outlook to at least $30.60 per share and outlined a multi-year $3 billion modernization and productivity program.

Cigna Group (NYSE:CI - Get Free Report) was upgraded by equities researchers at Wall Street Zen from a "hold" rating to a "buy" rating in a research report issued to clients and investors on Sunday, Wall Street Zen reports.

CI has been the topic of a number of other reports. Sanford C. Bernstein reiterated an "outperform" rating on shares of Cigna Group in a research note on Friday, October 2nd. UBS Group reissued a "buy" rating on shares of Cigna Group in a research note on Thursday, October 1st. Raymond James Financial cut shares of Cigna Group from a "strong-buy" rating to an "outperform" rating and dropped their price objective for the company from $350.00 to $320.00 in a report on Monday, August 3rd. Evercore initiated coverage on shares of Cigna Group in a report on Wednesday, September 9th. They issued an "in-line" rating and a $290.00 price objective for the company. Finally, Guggenheim cut their target price on shares of Cigna Group from $361.00 to $347.00 and set a "buy" rating on the stock in a research note on Friday. Fourteen investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. According to MarketBeat, Cigna Group has a consensus rating of "Moderate Buy" and a consensus target price of $335.70.

Cigna Group Trading Down 2.6%

Shares of NYSE CI opened at $293.66 on Friday. Cigna Group has a twelve month low of $255.53 and a twelve month high of $318.05. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.66. The stock has a fifty day simple moving average of $285.81 and a 200-day simple moving average of $282.17. The stock has a market capitalization of $77.60 billion, a PE ratio of 12.96, a PEG ratio of 0.99 and a beta of 0.25.

Cigna Group (NYSE:CI - Get Free Report) last posted its earnings results on Thursday, November 5th. The health services provider reported $7.98 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.52 by $0.46. Cigna Group had a return on equity of 19.57% and a net margin of 2.09%. The firm had revenue of $73.79 billion for the quarter, compared to analyst estimates of $72.64 billion. During the same quarter in the prior year, the company earned $7.83 EPS. Cigna Group's revenue was up 5.6% on a year-over-year basis. On average, equities analysts forecast that Cigna Group will post 30.62 earnings per share for the current year.

Insider Buying and Selling

In related news, insider Nicole S. Jones sold 2,677 shares of the business's stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total transaction of $748,515.97. Following the completion of the transaction, the insider owned 25,880 shares in the company, valued at approximately $7,236,306.80. The trade was a 9.37% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of the business's stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total transaction of $175,258.85. Following the transaction, the insider owned 5,053 shares of the company's stock, valued at approximately $1,435,304.65. The trade was a 10.88% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.60% of the company's stock.

Institutional Trading of Cigna Group

A number of institutional investors have recently bought and sold shares of CI. Osbon Capital Management LLC purchased a new stake in Cigna Group during the second quarter worth approximately $26,000. Putney Financial Group LLC acquired a new stake in Cigna Group during the third quarter worth approximately $27,000. Cedar Mountain Advisors LLC raised its holdings in Cigna Group by 161.9% during the first quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider's stock worth $29,000 after purchasing an additional 68 shares in the last quarter. Johnson Financial Group Inc. acquired a new stake in Cigna Group during the second quarter worth approximately $29,000. Finally, Fiduciary Financial Advisors purchased a new stake in shares of Cigna Group during the 2nd quarter worth approximately $29,000. 86.99% of the stock is owned by hedge funds and other institutional investors.

Cigna Group News Summary

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Third-quarter adjusted earnings were $7.98 per share, ahead of estimates, while revenue rose 6% to about $73.8 billion and also exceeded consensus. Strength in Cigna Healthcare and a favorable pharmacy benefit mix supported results. Cigna Q3 Earnings and Revenues Beat Estimates
• Positive Sentiment: Management raised its 2026 adjusted earnings outlook to at least $30.60 per share. Employer medical growth is expected to help offset Cigna’s exit from the ACA individual market. Cigna lifts 2026 outlook
• Positive Sentiment: At its investor event, Cigna outlined a multi-year $3 billion modernization and productivity program, targeting 10%–14% adjusted EPS growth annually and approximately $50 billion in cumulative operating cash flow through 2030. Cigna raises 2026 outlook after strong quarter
• Neutral Sentiment: Analyst views remain supportive: Cantor Fitzgerald reaffirmed Overweight with a $340 target. Guggenheim kept a Buy rating but lowered its target to $347 from $361, tempering the positive signal. Guggenheim ratings
• Negative Sentiment: Despite higher adjusted earnings, reported GAAP net income fell to $1.4 billion from $1.87 billion a year earlier. The ACA individual-market exit also brings transition and execution risks, even as employer business growth is expected to offset it. Cigna Group lifts outlook as revenue climbs

About Cigna Group

The Cigna Group is a global health services company that provides health insurance and related services through its Cigna Healthcare and Evernorth Health Services businesses. Cigna Healthcare offers medical, dental, behavioral health and other coverage and services to employers, individuals and government-program members.

Evernorth provides pharmacy benefit management, specialty pharmacy, care delivery and other health services. Its offerings include prescription drug benefits and services for people with complex or chronic conditions.

The company serves customers in the United States and select international markets.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.